Citi raises Xylem stock price target to $152, maintains buy rating

Published 05/02/2025, 11:58
Citi raises Xylem stock price target to $152, maintains buy rating

On Wednesday, Citi analyst Andrew Kaplowitz adjusted the price target for Xylem , a leading global water technology company with a market capitalization of $31.4 billion, signaling confidence in the firm’s growth potential. The new price target is set at $152.00, an increase from the previous $147.00, while the Buy rating remains unchanged. According to InvestingPro data, analyst targets for Xylem range from $114.15 to $168, with the stock currently trading near $129.24.

Kaplowitz’s stance comes after a review of Xylem’s fourth-quarter results and the company’s initial 2025 outlook. The anticipated adjusted EBITDA margin expansion of 70 to 120 basis points is seen as a result of successful simplification efforts by Xylem. These efforts are in line with the company’s long-term financial framework that was introduced in 2024. The company has demonstrated strong execution, with revenue growing 16.27% over the last twelve months.

Despite a projected modest dip in organic growth for 2025 to 3-4%, compared to Xylem’s long-term target of 4-6%, the analyst believes this was largely expected by the investment community. The company’s solid margin expansion outlook for 2025, even in the face of expected mix headwinds in the Measurement & Control Solutions (M&CS) segment, coupled with healthy organic order trends observed in the fourth quarter, are viewed as positive indicators of Xylem’s potential for sustained earnings growth.

Xylem’s commitment to operational efficiency and financial performance is underscored by the positive remarks from Citi, reflecting a broader investor sentiment that the company is on a firm path toward achieving its strategic financial goals.

Shares of Xylem (NYSE: XYL) are likely to be influenced by these developments, as the market processes the implications of the revised price target and the maintained Buy rating by Citi. The water technology company continues to navigate the competitive landscape with a focus on growth, margin improvement, and long-term shareholder value.

In other recent news, Xylem Inc (NYSE:XYL). has reported fourth-quarter earnings that exceeded analyst predictions, while issuing a cautious revenue forecast for 2025. The company’s adjusted earnings per share for Q4 were $1.18, surpassing the consensus estimate of $1.13. Additionally, Xylem’s revenue increased by 7% year-over-year, reaching $2.3 billion and exceeding expectations of $2.18 billion.

For the full year of 2024, the company reported a revenue of $8.6 billion, marking a 16% increase on a reported basis and a 6% organic increase from 2023. Adjusted earnings per share rose by 13% year-over-year to $4.27.

However, Xylem’s 2025 revenue forecast ranges between $8.6 billion and $8.7 billion, falling short of the $8.84 billion that analysts had anticipated. The company also projects an adjusted EBITDA margin of 21.3% to 21.8%, indicating an increase of 70 to 120 basis points from 2024. These recent developments provide crucial insights into Xylem’s financial performance and future expectations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.